JSR株式会社
JSRグループのライフサイエンス事業は「JSR Life Sciences」として、抗体医薬製造用材料（バイオプロセス用材料）、診断・研究試薬材料、抗体医薬開発・製造受託サービスを提供しています。
会社カテゴリー：原薬・添加剤・中間体、製造受託機関(CMO)、分析、試験受託サービス、医薬品製造関連資材、研究関連資材
主サービス提供地域：日本、アメリカ合衆国、中華人民共和国、大韓民国、台湾、ヨーロッパ(イギリス以外)、イギリス、インド
製品・サービス詳細
CELL LINE DEVELOPMENT 細胞株の構築（CHO細胞）
サービスカテゴリー：開発、分析、製造
Selexis is helping global partners advance complex biologics into the clinic faster, and ultimately help drive more life-saving biologic medicines to millions of waiting patients.
Selexisは動物細胞株構築に先進的に取り組むスイスのライフサイエンス企業です。多くの組み換えタンパク質を安定的かつ効率的に培養できる細胞株を、短期間で構築いたします。
Cell Line Development – stable, high-yield, and clonal mammalian cell lines
Selexis offers comprehensive and rapid solutions for the development of stable, high-yield, and clonal mammalian cell lines that are used in recombinant protein drug manufacturing.
By combining SUREtechnology Platform™ and world-class expertise, Selexis SURE Cell Line Development™ Services significantly reduce the time, effort, and costs that are associated with the development of high-performance mammalian cell lines for therapeutic protein production (e.g., development of monoclonal antibodies, bi-specific monoclonal antibodies, growth factors, Fc Fusions and enzymes).
The development of high-yield production cell lines starts with the cloning of the gene of interest into SUREtech Vectors™ that bear Selexis SGE® (Selexis Genetic Elements). These optimally designed DNA expression vectors are then transfected into the fully documented Selexis SURE CHO-M Cell Line™ using the SUREfection™ procedure.
By applying single cell cloning from the selected stable pools, Selexis identifies high-expressing clonal cell lines that are then evaluated for their growth characteristics using fed-batch cultures.
Innovation Every Step of the Way
